Keyphrases
Potential Therapeutics
100%
Phage
100%
Lytic Bacteriophage
100%
Klebsiella Pneumoniae B5055
100%
Kidney
75%
Urinary Bladder
75%
Bacteriophage
75%
Klebsiella Pneumoniae (K. pneumoniae)
25%
Therapeutic Agents
25%
Prophylactic Treatment
25%
Broad-host-range
25%
Infected Cells
25%
Head Circumference
25%
After Injection
25%
Titer
25%
Failure Cause
25%
Structural Proteins
25%
Plaque-forming Units
25%
Maximum Activity
25%
Protein Pattern
25%
Icosahedral
25%
Latent Period
25%
Growth Cycle
25%
Burst Size
25%
Wide pH Range
25%
Post-antibiotic Era
25%
Podoviridae
25%
Phage Therapy
25%
Phage Titer
25%
Catheter-associated UTI
25%
Immunology and Microbiology
Bacteriophage
100%
Klebsiella pneumoniae
100%
Bladder
27%
Viral Life Cycle
9%
Plaque-Forming Unit
9%
Latent Period
9%
Morphology
9%
Titer
9%
Host Range
9%
Podoviridae
9%
Phage Titer
9%